BARINTHUS BIOTHERAPEUTICS PLC Research and Development Expense
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Research and Development Expense of $3.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for the quarter ending 2026-06-30 was $3.92M, a 50.67% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for the quarter ending 2026-03-31 was $3.59M, a 56.66% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for the quarter ending 2025-12-31 was $3.93M, a 52.70% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for the quarter ending 2025-09-30 was $5.39M, a 51.61% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for fiscal 2025 was $25.56M, a 39.47% decline from fiscal 2024.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for fiscal 2024 was $42.24M, a 5.88% decline from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for fiscal 2023 was $44.87M, a 5.96% increase from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC research and development expense for fiscal 2022 was $42.35M, a 107.89% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.92M 10-Q · filed 2026-08-06 | $7.52M 10-Q · filed 2026-08-06 | $11.45M derived: sum of 3 quarters · filed 2026-08-06 | $16.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.59M 10-Q · filed 2026-04-30 | $7.52M derived: sum of 2 quarters · filed 2026-04-30 | $12.91M derived: sum of 3 quarters · filed 2026-04-30 | $20.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $9.32M derived: sum of 2 quarters · filed 2026-03-13 | $17.27M derived: sum of 3 quarters · filed 2026-08-06 | $25.56M 10-K · filed 2026-03-13 |
| 2025-09-30 | $5.39M 10-Q · filed 2025-11-07 | $13.34M derived: sum of 2 quarters · filed 2026-08-06 | $21.63M 10-Q · filed 2025-11-07 | $29.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.95M 10-Q · filed 2026-08-06 | $16.24M 10-Q · filed 2026-08-06 | $24.55M derived: sum of 3 quarters · filed 2026-08-06 | $35.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $8.29M 10-Q · filed 2026-04-30 | $16.60M derived: sum of 2 quarters · filed 2026-04-30 | $27.74M derived: sum of 3 quarters · filed 2026-04-30 | $39.40M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $19.45M derived: sum of 2 quarters · filed 2026-03-13 | $31.11M derived: sum of 3 quarters · filed 2026-03-13 | $42.24M 10-K · filed 2026-03-13 |
| 2024-09-30 | $11.14M 10-Q · filed 2025-11-07 | $22.80M derived: sum of 2 quarters · filed 2025-11-07 | $33.93M 10-Q · filed 2025-11-07 | $40.30M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $11.66M 10-Q · filed 2025-08-07 | $22.79M 10-Q · filed 2025-08-07 | $29.16M derived: sum of 3 quarters · filed 2025-08-07 | $44.30M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $11.13M 10-Q · filed 2025-05-07 | $17.50M derived: sum of 2 quarters · filed 2025-05-07 | $32.64M derived: sum of 3 quarters · filed 2025-05-07 | $46.19M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $21.52M derived: sum of 2 quarters · filed 2025-03-20 | $35.06M derived: sum of 3 quarters · filed 2025-03-20 | $44.87M 10-K · filed 2025-03-20 |
| 2023-09-30 | $15.14M 10-Q · filed 2024-11-06 | $28.69M derived: sum of 2 quarters · filed 2024-11-06 | $38.50M 10-Q · filed 2024-11-06 | $50.69M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $13.54M 10-Q · filed 2024-08-08 | $23.36M 10-Q · filed 2024-08-08 | $35.54M derived: sum of 3 quarters · filed 2024-08-08 | $45.29M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $9.81M 10-Q · filed 2024-05-13 | $22.00M derived: sum of 2 quarters · filed 2024-05-13 | $31.74M derived: sum of 3 quarters · filed 2024-05-13 | $41.46M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $12.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $21.93M derived: sum of 2 quarters · filed 2024-03-20 | $31.65M derived: sum of 3 quarters · filed 2024-03-20 | $42.35M 10-K · filed 2024-03-20 |
| 2022-09-30 | $9.74M 10-Q · filed 2023-11-09 | $19.46M derived: sum of 2 quarters · filed 2023-11-09 | $30.16M 10-Q · filed 2023-11-09 | $37.05M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $9.72M 10-Q · filed 2023-08-10 | $20.42M 10-Q · filed 2023-08-10 | $27.30M derived: sum of 3 quarters · filed 2023-08-10 | $31.67M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $10.70M 10-Q · filed 2023-05-12 | $17.58M derived: sum of 2 quarters · filed 2023-05-12 | $21.95M derived: sum of 3 quarters · filed 2023-05-12 | $26.46M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $11.25M derived: sum of 2 quarters · filed 2023-03-24 | $15.76M derived: sum of 3 quarters · filed 2023-03-24 | $20.37M 10-K · filed 2023-03-24 |
| 2021-09-30 | $4.37M 10-Q · filed 2022-11-10 | $8.88M derived: sum of 2 quarters · filed 2022-11-10 | $13.49M 10-Q · filed 2022-11-10 | $16.06M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.51M 10-Q · filed 2022-08-09 | $9.12M 10-Q · filed 2022-08-09 | $11.69M derived: sum of 3 quarters · filed 2022-08-09 | $15.39M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $4.61M 10-Q · filed 2022-05-11 | $7.18M derived: sum of 2 quarters · filed 2022-05-11 | $10.88M derived: sum of 3 quarters · filed 2022-05-11 | $14.76M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $6.27M derived: sum of 2 quarters · filed 2022-03-25 | $10.14M derived: sum of 3 quarters · filed 2022-03-25 | $14.39M 10-K · filed 2022-03-25 |
| 2020-09-30 | $3.70M 10-Q · filed 2021-11-12 | $7.58M derived: sum of 2 quarters · filed 2021-11-12 | $11.82M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $3.88M 10-Q · filed 2021-08-12 | $8.12M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $4.24M 10-Q · filed 2021-06-14 |